Effect of Lycopene on Oral Squamous Cell Carcinoma Cell Growth by Inhibiting IGF1 Pathway

References

• Mestrinho LA. Current status and future perspectives in canine oral squamous cell carcinoma. Vet Pathol. 2018;55(2):200–201. doi:10.1177/030098581773211429457565
   PubMed Web of Science ®Google Scholar
• Gupta B, Bray F, Kumar N, et al. Associations between oral hygiene habits, diet, tobacco and alcohol and risk of oral cancer: a case-control study from India. Cancer Epidemiol. 2017;51:7–14. doi:10.1016/j.canep.2017.09.00328968558
   PubMed Web of Science ®Google Scholar
• Serna-Thomé G, Castro-Eguiluz D, Fuchs-Tarlovsky V, et al. Use of functional foods and oral supplements as adjuvants in cancer treatment. Rev Invest Clin. 2018;70(3):136–146. doi:10.24875/RIC.1800252729943769
   PubMedGoogle Scholar
• Lu R, Dan H, Wu R, et al. Lycopene: features and potential significance in the oral cancer and precancerous lesions. J Oral Pathol Med. 2011;40(5):361–368. doi:10.1111/j.1600-0714.2010.00991.x21198870
   PubMed Web of Science ®Google Scholar
• Saran G, Umapathy D, Misra N, et al. A comparative study to evaluate the efficacy of lycopene and curcumin in oral submucous fibrosis patients: a randomized clinical trial. Indian J Dent Res. 2018;29(3):303–312. doi:10.4103/ijdr.IJDR_551_1629900913
   PubMedGoogle Scholar
• Nagao T, Ikeda N, Warnakulasuriya S, et al. Serum antioxidant micronutrients and the risk of oral leukoplakia among Japanese. Oral Oncol. 2000;36(5):466–470. doi:10.1016/S1368-8375(00)00037-310964055
   PubMed Web of Science ®Google Scholar
• Maserejian NN, Giovannucci E, Rosner B, et al. Prospective study of vitamins C, E, and A and carotenoids and risk of oral premalignant lesions in men. Int J Cancer. 2006;120(5):970–977. doi:10.1002/ijc.22448
   Web of Science ®Google Scholar
• Wang R, Lu X, Yu R. Lycopene inhibits epithelial-mesenchymal transition and promotes apoptosis in oral cancer via PI3K/AKT/m-TOR signal pathway. Drug Des Devel Ther. 2020;14:2461–2471. doi:10.2147/DDDT.S251614
   PubMed Web of Science ®Google Scholar
• Grabowska M, Wawrzyniak D, Rolle K, et al. Let food be your medicine: nutraceutical properties of lycopene. Food Funct. 2019;10(6):3090–3102. doi:10.1039/C9FO00580C31120074
   PubMed Web of Science ®Google Scholar
• Kim M, Kim SH, Lim JW, et al. Lycopene induces apoptosis by inhibiting nuclear translocation of β-catenin in gastric cancer cells. J Physiol Pharmacol. 2019;70(4). doi:10.26402/jpp.2019.4.11.
   Web of Science ®Google Scholar
• Jeong Y, Lim JW, Kim H. Lycopene inhibits reactive oxygen species-mediated NF-κB signaling and induces apoptosis in pancreatic cancer cells. Nutrients. 2019;11(4):762. doi:10.3390/nu11040762
   PubMed Web of Science ®Google Scholar
• Iams WT, Lovly CM. Molecular pathways: clinical applications and future direction of insulin-like growth factor-1 receptor pathway blockade. Clin Cancer Res. 2015;21(19):4270–4277. doi:10.1158/1078-0432.CCR-14-251826429980
   PubMed Web of Science ®Google Scholar
• Liu L, Wang X, Li X, et al. Upregulation of IGF1 by tumor-associated macrophages promotes the proliferation and migration of epithelial ovarian cancer cells. Oncol Rep. 2018;39(2):818–826. doi:10.3892/or.2017.614829251331
   PubMed Web of Science ®Google Scholar
• Ostermann AL, Wunderlich CM, Schneiders L, et al. Intestinal insulin/IGF1 signalling through FoxO1 regulates epithelial integrity and susceptibility to colon cancer. Nat Metab. 2019;1(3):371–389. doi:10.1038/s42255-019-0037-832694718
   PubMedGoogle Scholar
• Xu GP, Chen WX, Xie WY, et al. The association between IGF1 gene rs1520220 polymorphism and cancer susceptibility: a meta-analysis based on 12,884 cases and 58,304 controls. Environ Health Prev Med. 2018;23(1):38. doi:10.1186/s12199-018-0727-y30111277
   PubMed Web of Science ®Google Scholar
• Tjahjodjati SS, Umbas R, Satari M. The protective effect of lycopene on prostate growth inhibitory efficacy by decreasing insulin growth factor-1 in Indonesian human prostate cancer cells. Res Rep Urol. 2020;12:137–143. doi:10.2147/RRU.S23274532368526
   PubMed Web of Science ®Google Scholar
• Tang FY, Pai MH, Kuo YH, et al. Concomitant consumption of lycopene and fish oil inhibits tumor growth and progression in a mouse xenograft model of colon cancer. Mol Nutr Food Res. 2012;56(10):1520–1531. doi:10.1002/mnfr.20120009822961879
   PubMed Web of Science ®Google Scholar
• Yang CM, Yen YT, Huang CS, et al. Growth inhibitory efficacy of lycopene and β-carotene against androgen-independent prostate tumor cells xenografted in nude mice. Mol Nutr Food Res. 2011;55(4):606–612. doi:10.1002/mnfr.20100030821462328
   PubMed Web of Science ®Google Scholar
• Singh M, Krishanappa R, Bagewadi A, et al. Efficacy of oral lycopene in the treatment of oral leukoplakia. Oral Oncol. 2004;40(6):591–596. doi:10.1016/j.oraloncology.2003.12.01115063387
   PubMed Web of Science ®Google Scholar
• Kumar A, Bagewadi A, Keluskar V, et al. Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103(2):207–213. doi:10.1016/j.tripleo.2006.07.01117234537
   PubMed Web of Science ®Google Scholar
• Elgass S, Cooper A, Chopra M. Lycopene treatment of prostate cancer cell lines inhibits adhesion and migration properties of the cells. Int J Med Sci. 2014;11(9):948–954. doi:10.7150/ijms.913725076850
   PubMed Web of Science ®Google Scholar
• Rajbhandari N, Lin W-C, Wehde BL, et al. Autocrine IGF1 signaling mediates pancreatic tumor cell dormancy in the absence of oncogenic drivers. Cell Rep. 2017;18(9):2243–2255. doi:10.1016/j.celrep.2017.02.01328249168
   PubMed Web of Science ®Google Scholar
• Elferink LA, Resto VA. Receptor-tyrosine-kinase-targeted therapies for head and neck cancer. J Signal Transduct. 2011;2011:982879. doi:10.1155/2011/98287921776391
   PubMedGoogle Scholar
• Karas M, Amir H, Fishman D, et al. Lycopene interferes with cell cycle progression and insulin-like growth factor I signalling in mammary cancer cells. Nutr Cancer. 2000;36(1):101–111. doi:10.1207/S15327914NC3601_1410798222
   PubMed Web of Science ®Google Scholar
• Xu H, Jin X, Yuan Y, et al. Prognostic value from integrative analysis of transcription factors c-Jun and Fra-1 in oral squamous cell carcinoma: a multicenter cohort study. Sci Rep. 2017;7(1):7522. doi:10.1038/s41598-017-05106-528790303
   PubMed Web of Science ®Google Scholar
• Nahum A, Zeller L, Danilenko M, et al. Lycopene inhibition of IGF-induced cancer cell growth depends on the level of cyclin D1. Eur J Nutr. 2006;45(5):275–282. doi:10.1007/s00394-006-0595-x16565789
   PubMed Web of Science ®Google Scholar
• Jiang B, Zhang X, Du -L-L, et al. Possible roles of insulin, IGF-1 and IGFBPs in initiation and progression of colorectal cancer. World J Gastroenterol. 2014;20(6):1608–1613. doi:10.3748/wjg.v20.i6.160824587638
   PubMed Web of Science ®Google Scholar
• Valadez-Bustos N, Escamilla-Silva EM, García-Vázquez FJ, et al. Oral administration of microencapsulated B. longum BAA-999 and lycopene modulates IGF-1/IGF-1R/IGFBP3 protein expressions in a colorectal murine model. Int J Mol Sci. 2019;20(17):4275. doi:10.3390/ijms20174275
   PubMed Web of Science ®Google Scholar
• Song H, Lai L, Liu M, et al. Investigating the role and mechanism of microRNA-196a in oral squamous cell carcinoma by targeting FOXO1. Exp Ther Med. 2020;19(6):3707–3715. doi:10.3892/etm.2020.861432346435
   PubMed Web of Science ®Google Scholar
• Zheng M, Cao M-X, Yu X-H, et al. STAT3 promotes invasion and aerobic glycolysis of human oral squamous cell carcinoma via inhibiting FoxO1. Front Oncol. 2019;9:1175. doi:10.3389/fonc.2019.0117531750256
   PubMed Web of Science ®Google Scholar